secwatch.observer — SEC 8-K summary
======================================

Issuer:     Equillium, Inc. (EQ)
CIK:        0001746466
Form:       8-K
Filed at:   2023-04-06T23:59:59+00:00
Accession:  0001193125-23-093949
Event type: regulatory
Sentiment:  negative
Materiality: 0.60
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Equillium receives Nasdaq bid price deficiency notice; has until Oct 2, 2023 to regain compliance
--------------------------------------------------------------------------------

- Nasdaq notified Equillium on April 5, 2023 that its common stock bid price closed below $1.00 for 30 consecutive business days.
- Company has 180 calendar days, until October 2, 2023, to regain compliance by closing at $1.00 or more for 10 consecutive business days.
- If not compliant by Oct 2, Equillium may transfer to Nasdaq Capital Market for an additional 180-day cure period, subject to meeting other listing standards.
- Company is considering available options, including a reverse stock split, to cure the deficiency.
- Non-compliance has no immediate effect on listing or trading of EQ common stock on Nasdaq Global Market.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1746466/000119312523093949/0001193125-23-093949-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1746466/000119312523093949/d476859d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-093949

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer